These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 7504473)
1. Altered ligand specificity of proteolysed insulin-like growth factor binding protein-3. Baxter RC; Skriver L Biochem Biophys Res Commun; 1993 Nov; 196(3):1267-73. PubMed ID: 7504473 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the binding defect in insulin-like growth factor binding protein-3 from pregnancy serum. Baxter RC; Suikkari AM; Martin JL Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):847-52. PubMed ID: 7691057 [TBL] [Abstract][Full Text] [Related]
3. Measurement of intact insulin-like growth factor-binding protein-3 in human plasma using a ligand immunofunctional assay. Lassarre C; Binoux M J Clin Endocrinol Metab; 2001 Mar; 86(3):1260-6. PubMed ID: 11238518 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs. Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979 [TBL] [Abstract][Full Text] [Related]
5. The roles of tyrosines 24, 31, and 60 in the high affinity binding of insulin-like growth factor-I to the type 1 insulin-like growth factor receptor. Bayne ML; Applebaum J; Chicchi GG; Miller RE; Cascieri MA J Biol Chem; 1990 Sep; 265(26):15648-52. PubMed ID: 2168421 [TBL] [Abstract][Full Text] [Related]
7. Evidence that limited proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3) occurs in the normal state outside of the bloodstream. Lalou C; Binoux M Regul Pept; 1993 Oct; 48(1-2):179-88. PubMed ID: 7505464 [TBL] [Abstract][Full Text] [Related]
8. Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs. Clemmons DR; Dehoff ML; Busby WH; Bayne ML; Cascieri MA Endocrinology; 1992 Aug; 131(2):890-5. PubMed ID: 1379166 [TBL] [Abstract][Full Text] [Related]
9. Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex. Bang P; Brismar K; Rosenfeld RG J Clin Endocrinol Metab; 1994 May; 78(5):1119-27. PubMed ID: 7513716 [TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma. Lassarre C; Binoux M Endocrinology; 1994 Mar; 134(3):1254-62. PubMed ID: 7509737 [TBL] [Abstract][Full Text] [Related]
11. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability. Lindgren BF; Segovia B; Lassarre C; Binoux M; Gourmelen M Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649 [TBL] [Abstract][Full Text] [Related]
12. Proteolysis of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in 150-kilodalton IGFBP complexes by a cation-dependent protease activity in adult rat serum promotes the release of bound IGF-I. Lee CY; Rechler MM Endocrinology; 1996 May; 137(5):2051-8. PubMed ID: 8612547 [TBL] [Abstract][Full Text] [Related]
13. A major portion of the 150-kilodalton insulin-like growth factor-binding protein (IGFBP) complex in adult rat serum contains unoccupied, proteolytically nicked IGFBP-3 that binds IGF-II preferentially. Lee CY; Rechler MM Endocrinology; 1995 Feb; 136(2):668-78. PubMed ID: 7530649 [TBL] [Abstract][Full Text] [Related]
14. In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. Blat C; Villaudy J; Binoux M J Clin Invest; 1994 May; 93(5):2286-90. PubMed ID: 7514194 [TBL] [Abstract][Full Text] [Related]
15. Effects of glucocorticoids on circulating levels and hepatic expression of insulin-like growth factor (IGF)-binding proteins and IGF-I in the adrenalectomized streptozotocin-diabetic rat. Unterman TG; Jentel JJ; Oehler DT; Lacson RG; Hofert JF Endocrinology; 1993 Dec; 133(6):2531-9. PubMed ID: 7694841 [TBL] [Abstract][Full Text] [Related]
16. Structural determinants for binary and ternary complex formation between insulin-like growth factor-I (IGF-I) and IGF binding protein-3. Baxter RC; Bayne ML; Cascieri MA J Biol Chem; 1992 Jan; 267(1):60-5. PubMed ID: 1370451 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated. Näntö-Salonen K; Muller HL; Hoffman AR; Vu TH; Rosenfeld RG Endocrinology; 1993 Feb; 132(2):781-8. PubMed ID: 7678799 [TBL] [Abstract][Full Text] [Related]
18. Characterization of insulin-like growth factor binding proteins (IGFBPs) during gestation in mice: effects of hypophysectomy and an IGFBP-specific serum protease activity. Fielder PJ; Thordarson G; Talamantes F; Rosenfeld RG Endocrinology; 1990 Nov; 127(5):2270-80. PubMed ID: 1699743 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of the acid-labile subunit of the growth-hormone-dependent insulin-like-growth-factor-binding protein complex by rat hepatocytes in culture. Scott CD; Baxter RC Biochem J; 1991 Apr; 275 ( Pt 2)(Pt 2):441-6. PubMed ID: 1709006 [TBL] [Abstract][Full Text] [Related]
20. Serum insulin-like growth factor-binding protein-3 (IGFBP-3) levels and IGFBP-3 protease activity in normal, abnormal, and multiple human pregnancy. Langford KS; Nicolaides KH; Jones J; Abbas A; McGregor AM; Miell JP J Clin Endocrinol Metab; 1995 Jan; 80(1):21-7. PubMed ID: 7530257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]